IMM 1.49% 34.0¢ immutep limited

oversold on panic!, page-16

  1. 5,418 Posts.
    lightbulb Created with Sketch. 130
    Why have you related PRR selling to the Dendreon result? C
    This is an insto dump

    On Dendreon though "the Provenge launch isn't typical since Dendreon can't make enough to satisfy patient demand. The company long ago told investors that limited manufacturing capacity would only allow about 2,000 patients to be treated in the first 12 months of the launch.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.